Wang Chen, Wang Huan, Chang Dong-Yuan, Hao Jian, Zhao Ming-Hui, Chen Min
Department of Medicine, Renal Division, Peking University First Hospital; Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, 8, Xishiku Street, Beijing, 100034, China.
Arthritis Res Ther. 2015 Mar 18;17(1):64. doi: 10.1186/s13075-015-0587-4.
High mobility group box-1 (HMGB1), a typical damage-associated molecular pattern (DAMP) protein, is associated with inflammatory conditions and tissue damage. Our recent study found that circulating HMGB1 levels could reflect the disease activity of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). The current study aimed to investigate whether HMGB1 participated in ANCA-induced neutrophil activation, which is one of the most important pathogenic aspects in the development of AAV.
The various effects of HMGB1 in ANCA-induced neutrophil activation were measured. Antagonists for relevant receptors and signaling molecules were employed.
ANCA antigens translocation on neutrophils primed with HMGB1 was significantly higher than non-primed neutrophils. The levels of respiratory burst and degranulation increased significantly in HMGB1-primed neutrophils activated with ANCA-positive IgG, as compared with non-primed neutrophils. Furthermore, blocking Toll-like receptor 4 (TLR4) and receptor for advanced glycation end products (RAGE), rather than TLR2, resulted in a significant decrease in HMGB1-induced ANCA antigens translocation, respiratory burst and degranulation. Similar effects were also found when blocking MyD88 and NF-κB.
HMGB1 could prime neutrophils by increasing ANCA antigens translocation, and the primed neutrophils could be further induced by ANCA, resulting in the respiratory burst and degranulation. This process is TLR4- and RAGE-dependent through the MyD88/NF-κB pathway.
高迁移率族蛋白B1(HMGB1)是一种典型的损伤相关分子模式(DAMP)蛋白,与炎症状态和组织损伤相关。我们最近的研究发现,循环中的HMGB1水平可反映抗中性粒细胞胞浆抗体(ANCA)相关血管炎(AAV)的疾病活动度。本研究旨在探讨HMGB1是否参与ANCA诱导的中性粒细胞活化,而这是AAV发病过程中最重要的致病环节之一。
检测HMGB1在ANCA诱导的中性粒细胞活化中的各种作用。使用相关受体和信号分子的拮抗剂。
用HMGB1预处理的中性粒细胞上ANCA抗原的易位显著高于未预处理的中性粒细胞。与未预处理的中性粒细胞相比,用ANCA阳性IgG激活的经HMGB1预处理的中性粒细胞的呼吸爆发和脱颗粒水平显著增加。此外,阻断Toll样受体4(TLR4)和晚期糖基化终产物受体(RAGE),而非TLR2,可导致HMGB1诱导的ANCA抗原易位、呼吸爆发和脱颗粒显著减少。阻断髓样分化因子88(MyD88)和核因子κB(NF-κB)时也发现了类似的效果。
HMGB1可通过增加ANCA抗原易位来预处理中性粒细胞,而经预处理的中性粒细胞可被ANCA进一步诱导,导致呼吸爆发和脱颗粒。这个过程通过MyD88/NF-κB途径依赖于TLR4和RAGE。